+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the use of oscillometry and fractional exhaled nitric oxide FeNO testing in primary care to diagnose asthma and chronic obstructive pulmonary disease COPD. The study compares these methods to specialist-based diagnosis, aiming to address challenges with spirometry, such as patient effort, technical difficulties, and reproducibility, which affect diagnostic accuracy especially in primary care settings. This observational study is conducted across 7 countries in the Middle East, Africa, Asia, and Latin America at hospital sites, focusing on patients with suspected asthma or COPD. Primary care physicians are trained to use oscillometry and FeNO testing following international guidelines, using tools like the Ambulatory Lung Diagnosis System. Patients suspected of asthma or COPD undergo symptom questionnaires and primary care assessment with these tests. If specialist diagnosis cannot be done same day, it occurs within three days. There are no follow-up visits planned. The study aims to assess the technical feasibility and diagnostic accuracy of these tools in routine primary care compared to specialist diagnosis. Participants provide consent, complete history and symptom questionnaires, and undergo oscillometry and FeNO testing at primary care sites. Diagnostic accuracy is measured by comparing primary care results to specialist diagnoses using statistical metrics like Cohens kappa, sensitivity, and specificity within 1 to 3 days. No additional follow-up or long-term monitoring is planned. The studys findings will help determine if these methods can improve early and accurate diagnosis of asthma and COPD in primary care.

Age: 18Years +All Genders
12 locations